Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10453)
All Articles published online
|
Publishing Process of This Article
|
May 21, 2016 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hunt CM, Beste LA, Lowy E, Suzuki A, Moylan CA, Tillmann HL, Ioannou GN, Lim JK, Kelley MJ, Provenzale D. Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration. World J Gastroenterol 2016; 22(19): 4732-4740 [PMID: 27217704 DOI: 10.3748/wjg.v22.i19.4732] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i19/4732.htm |
| Number | Citing Articles |
| 1 |
Patrik Garren, Marina Serper. Chronic Hepatitis B in US Veterans. Current Hepatology Reports 2019; 18(3): 310 doi: 10.1007/s11901-019-00479-9
|
| 2 |
Mahnur Haider, Gianina Flocco, Rocio Lopez, William Carey. Retrospective observational study of temporal trends and outcomes of hepatitis B screening in patients receiving rituximab. BMJ Open 2020; 10(12): e043672 doi: 10.1136/bmjopen-2020-043672
|
| 3 |
Urbano Sbarigia, Furaha Kariburyo, Janvi Sah, Jamie Colasurdo, Lin Xie, Eva G. Katz, Shirley Sylvester. Evaluating the Effect of Standard of Care Treatment on Burden of Chronic Hepatitis B: A Retrospective Analysis of the United States Veterans Population. Advances in Therapy 2020; 37(3): 1156 doi: 10.1007/s12325-020-01240-1
|
| 4 |
Jason T. Blackard, Kenneth E. Sherman. Hepatitis B virus (HBV) reactivation—The potential role of direct‐acting agents for hepatitis C virus (HCV). Reviews in Medical Virology 2018; 28(4) doi: 10.1002/rmv.1984
|
| 5 |
Cara D. Varley, Kevin L. Winthrop. Long-Term Safety of Rituximab (Risks of Viral and Opportunistic Infections). Current Rheumatology Reports 2021; 23(9) doi: 10.1007/s11926-021-01037-3
|
| 6 |
Lok-Ka Lam, Thomas Sau Yan Chan, Yu-Yan Hwang, Lung-Yi Mak, Wai-Kay Seto, Yok-Lam Kwong, Man-Fung Yuen. Hepatitis B virus reactivation in seronegative occult hepatitis B patient receiving ibrutinib therapy. Virology Journal 2023; 20(1) doi: 10.1186/s12985-023-02140-w
|
| 7 |
Ye Eun Kwak, Stacy M. Stein, Joseph K. Lim. Practice Patterns in Hepatitis B Virus Screening Before Cancer Chemotherapy in a Major US Hospital Network. Digestive Diseases and Sciences 2018; 63(1): 61 doi: 10.1007/s10620-017-4850-1
|
| 8 |
Sirish Sanaka, Hans L Tillmann. Article Commentary: Hindsight is 20/20 – the Importance of Knowing! Know your Patients’ HBV Status. Antiviral Therapy 2018; 23(6): 471 doi: 10.3851/IMP3260
|